Fig. 1From: Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteinsThe anti-cancer activity of doxorubicin on MDA-MB-231 and MCF-7 breast cancer cell lines. (a) Dose-response curves of 2D and 3D MDA-MB-231 and MCF-7 cultured cells. (b) Brightfield morphology of 3D cultured breast cancer cells following exposure to doxorubicin. Scale bar = 50 μm. Data represent mean ± standard deviationBack to article page